Programme

HKT
Lecture Theatre 1A
Lecture Theatre 1B
Room 209
  • 09:00
  • 09:10
  • 09:20
  • 09:30
  • 09:40
  • 09:50
  • 10:00
  • 10:10
  • 10:20
  • 10:30
  • 10:40
  • 10:50
  • 11:00
  • 11:10
  • 11:20
  • 11:30
  • 11:40
  • 11:50
  • 12:00
  • 12:10
  • 12:20
  • 12:30
  • 12:40
  • 12:50
  • 13:00
  • 13:10
  • 13:20
  • 13:30
  • 13:40
  • 13:50
  • 14:00
  • 14:10
  • 14:20
  • 14:30
  • 14:40
  • 14:50
  • 15:00
  • 15:10
  • 15:20
  • 15:30
  • 15:40
  • 15:50
  • 16:00
Lecture Theatre 1A
Lecture Theatre 1B
  • 09:00-10:30
    09:00-10:30
    State Key Lab Meeting (3) - Microbiome and host response
    By: Emad EL-OMAR, Jingyuan FU, Rhonda SOUZA
  • 10:30-11:00
    10:30-11:00
    Break
  • 11:00-12:30
    11:00-12:30
    State Key Lab Meeting (4) - Microbiome and cancer therapy
    By: Eran ELINAV, Howard HANG, Christian JOBIN
  • 12:30-13:30
    12:30-13:30
    Lunch
  • 13:30-14:30
    13:30-14:30
    Lunch Symposium (D)
  • 14:30-16:00
    14:30-16:00
    General hepatology updates
    By: Stephen CHAN, Michael MANNS, Roberto de FRANCHIS
Room 209
Irritable Bowel Syndrome: Food, Poop and Drugs
Lecture Theatre 1A
09:00-10:30
09:00
Lifestyle and dietary advances in IBS management
09:25
FMT in IBS management: ready for prime time?
09:50
New drugs in IBS
10:15
Q & A
State Key Lab Meeting (3) - Microbiome and host response
Lecture Theatre 1B
09:00-10:30
09:00
Microbiome in GI cancer
09:25
Genetic stability and individual specificity of the human gut microbiome
09:50
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
10:15
Q & A
Asian Frontiers in GI Endoscopy (AFGIE) Symposium
Room 209
09:00-10:30
09:00
Endoscopic tissue approximation in management of GI diseases
09:20
Current status of EUS-guided portal pressure gradient measurement
09:40
Tricks to enhance adenoma detection rate in colonoscopy: second look, mucosal exposure device, or AI?
10:00
Troubleshooting difficult bile duct access: advanced ERCP cannulation techniques or EUS guided biliary access?
10:20
Q & A
GI cancer: from prevention to cure
Lecture Theatre 1A
11:00-12:30
11:00
Non-invasive biomarkers for colorectal cancer: recent guidelines
11:25
Prevention of GI cancer: dream or reality?
11:50
What’s new in upper GI cancer treatment?
12:15
Q & A
State Key Lab Meeting (4) - Microbiome and cancer therapy
Lecture Theatre 1B
11:00-12:30
11:00
Microbiome and anti-cancer therapy
11:25
Enterococcus and cancer immunotherapy
11:50
Targeting microbiome for cancer prevention/treatment
12:15
Q & A
Towards control of viral hepatitis
Room 209
11:00-12:30
11:00
Eliminating HCV in lockdown
11:25
Disease burden of viral hepatitis in Hong Kong – should we treat more?
11:50
Will immunomodulatory treatment contribute to HBV elimination?
12:15
Q & A
Lunch Symposium (C)
Lecture Theatre 1A
13:30-14:30
13:30
Elevating crohn’s disease treatment goals – can we expect more?
13:55
The next stage of the ulcerative colitis journey
14:20
Q & A
Lunch Symposium (D)
Lecture Theatre 1B
13:30-14:30
13:30
Lunch Symposium (D)
COVID-19 and the GUT: lessons learnt
Lecture Theatre 1A
14:30-16:00
14:30
Gut microbiome and vaccine response
14:55
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:20
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
15:45
Q & A
General hepatology updates
Lecture Theatre 1B
14:30-16:00
14:30
Systemic treatments for HCC
14:55
Updates in autoimmune liver diseases
15:20
What is new in the Baveno VII consensus?
15:45
Q & A
** Programme is subject to change without prior notice